Related Experiment Video

Updated: Jun 6, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Enzyme studies in human liver and adipose tissue

E Shrago1, J A Glennon, E S Gordon

  • 1Department of Medicine, University of Wisconsin Medical School, Madison, Wisconsin, USA.

Nature
|November 25, 2010
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Related Experiment Videos

Last Updated: Jun 6, 2026

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro
09:41

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

Assessing Whole-Body Lipid-Handling Capacity in Mice
07:57

Assessing Whole-Body Lipid-Handling Capacity in Mice

Published on: November 24, 2020

Related Concept Videos

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...

Articles linked to this work by shared authors, journal, and citation graph.

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.

Public health genomics·2011

Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder.

Neurology·2008

The ABC's of limb-girdle muscular dystrophy: alpha-sarcoglycanopathy, Bethlem myopathy, calpainopathy and more.

Current opinion in neurology·2001

Determination of paroxetine levels in human plasma using gas chromatography with electron-capture detection.

Journal of chromatography. B, Biomedical sciences and applications·2001

Coronary heart disease mortality among Arab and Jewish residents of Jerusalem.

Lancet (London, England)·2000

Long-chain acyl-CoA as a multi-effector ligand in cellular metabolism.

The Journal of nutrition·2000

Uncoupling of energy metabolism and myocardial function in early left atrial dysfunction: a metabolomics study.

Frontiers in cardiovascular medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us